title: The combination of resveratrol and CLA does not increase the delipidating effect of each molecule in 3T3-L1 adipocytes.
abstract: BACKGROUND
  Trans-10, cis-12 conjugated linoleic acid (CLA) and resveratrol have been shown to reduce TG content in cultured 3T3-L1 adipocyte acting on different pathways. In recent years, the method of simultaneously targeting several signal transduction pathways with multiple natural products in order to achieve additive or synergistic effects has been tested. However, the combined effect of both molecules on lipid metabolism has not been described before.
  
  
  OBJECTIVE
  The aim of the present work was to analyze the effect of the combination of trans-10, cis-12 CLA and resveratrol on TG accumulation as well as on FAS, HSL and ATGL expression in 3T3-L1 mature adipocytes, in order to assess a potential interaction between both molecules.
  
  
  METHODS
  For this purpose, 3T3-L1 mature adipocytes were treated with the two molecules, both separately and combined, in 10 and 100 μM for 20 hours. TG content and FAS, ATGL and HSL expression were measured by spectrophotometry and Real Time RT-PCR respectively.
  
  
  RESULTS
  Both doses of CLA and 100 M resveratrol decreased TG content in mature adipocytes. The combination of both molecules reduced TG accumulation to the same extent as each one separately. No change in FAS and HSL mRNA levels after CLA and resveratrol treatment was observed. ATGL was not modified by CLA but it was increased by resveratrol and by the combination. This combination did not increase the effect caused by resveratrol on its own.
  
  
  CONCLUSIONS
  Lipolysis increase via ATGL is involved in the TG reduction induced by resveratrol and the combination of both molecules. The combination of these two molecules does not increase the efficacy of each molecule separately in mature adipocytes and thus it does not represent an advantage for obesity treatment or prevention.
authors.affiliation: Department of Nutrition and Food Science, University of Pais Vasco, Vitoria, Spain.
authors.forename: A
authors.initials: A
authors.lastname: Lasa
authors.forename: J
authors.initials: J
authors.lastname: Miranda
authors.forename: I
authors.initials: I
authors.lastname: Churruca
authors.forename: E
authors.initials: E
authors.lastname: Simón
authors.forename: N
authors.initials: N
authors.lastname: Arias
authors.forename: F
authors.initials: F
authors.lastname: Milagro
authors.forename: J A
authors.initials: JA
authors.lastname: Martínez
authors.forename: Ma del Puy
authors.initials: MP
authors.lastname: Portillo
mesh_terms: D041721:3T3-L1 Cells; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D064429:Fatty Acid Synthases / Q000032:analysis / Q000235:genetics; D007202:Indicators and Reagents; D019787:Linoleic Acid / Q000494:pharmacology*; D008049:Lipase / Q000032:analysis / Q000235:genetics; D050356:Lipid Metabolism / Q000187:drug effects*; D008066:Lipolysis / Q000187:drug effects; D051379:Mice; D012313:RNA / Q000032:analysis / Q000096:biosynthesis / Q000235:genetics; D060888:Real-Time Polymerase Chain Reaction; D000077185:Resveratrol; D002787:Sterol Esterase / Q000032:analysis / Q000235:genetics; D013267:Stilbenes / Q000494:pharmacology*; D014280:Triglycerides / Q000032:analysis
chemical_list: D000975:Antioxidants; D007202:Indicators and Reagents; D013267:Stilbenes; D014280:Triglycerides; D012313:RNA; D019787:Linoleic Acid; D064429:Fatty Acid Synthases; D002787:Sterol Esterase; D008049:Lipase; D000077185:Resveratrol